Pattern Recognition and Anomaly Detection in Fetal Morphology Using Deep Learning and Statistical Learning

NCT ID: NCT05738954

Last Updated: 2023-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

4000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-04

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Congenital anomalies (CA) are the most encountered cause of fetal death, infant mortality and morbidity.7.9 million infants are born with CA yearly. Early detection of CA facilitates life-saving treatments and stops the progression of disabilities. CA can be diagnosed prenatally through Morphology Scan (MS). Discrepancies between pre and postnatal diagnosis of CA reach 29%. A correct interpretation of MS allows a detailed discussion regarding the prognosis with parents. The central feature of PARADISE is the development of a specialized intelligent system that embeds a committee of Deep Learning and Statistical Learning methods, which work together in a competitive/collaborative way to increase the performance of MS examinations by signaling CA. Using preclinical testing and clinical validation, the main goal will be the direct implementation into clinical practice. This multi-disciplinary project offers a unique integration of approaches, competences, breakthroughs in key applications in human, psychological, technological, and economical interest such as the 'smarter' healthcare system, opening new fields of research. PARADISE creates an environment that contributes significantly to the healthcare system, medical and pharma industries, scientific community, economy and ultimately to each individual. Its outcome will increase impact on the management of CA by enabling the establishment of detailed plans before birth, which will decrease morbidity and mortality in infants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Probe guidance: The IS guides the sonographer's probe for better acquisition of the fetal biometric plane - Basic scanning to be performed by non-expert(\> 90% accuracy (AC)) Fetal biometric plane finder: The fetal planes are automatically detected, measured and stored - Insurance that all anatomical parts are checked (100% AC) Anomaly detection: unusual findings are signaled - Assistance in decision making (\>90% AC)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Abnormalities

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Second trimester

Second trimester fetal morphology Collect patient data, anonymize and label it. Written informed consent or verbal recorded consent (if the participant lacks the ability to write or sign) will be obtained before performing the MS. In the unlikely event that some of the participants will withdraw their consent after the ultrasound has been performed, the data collected will not be used in the project. Data for publications and dataset will be previously made anonymous following standard practices. The participants will sign a GDPR form.

Ultrasound

Intervention Type OTHER

Collect patient data, anonymize and label it. Written informed consent or verbal recorded consent (if the participant lacks the ability to write or sign) will be obtained before performing the MS. In the unlikely event that some of the participants will withdraw their consent after the ultrasound has been performed, the data collected will not be used in the project. Data for publications and dataset will be previously made anonymous following standard practices. The participants will sign a GDPR form.

The DL/SL algorithms will work in a competitive/collaborative way. Following the 'no-free-lunch' theorem, we shall use the competitive phase to establish the most suitable DL/SL technique for the identification and anomaly detection of each organ, and the collaborative phase to make all the algorithms work together in providing a 'second' opinion.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound

Collect patient data, anonymize and label it. Written informed consent or verbal recorded consent (if the participant lacks the ability to write or sign) will be obtained before performing the MS. In the unlikely event that some of the participants will withdraw their consent after the ultrasound has been performed, the data collected will not be used in the project. Data for publications and dataset will be previously made anonymous following standard practices. The participants will sign a GDPR form.

The DL/SL algorithms will work in a competitive/collaborative way. Following the 'no-free-lunch' theorem, we shall use the competitive phase to establish the most suitable DL/SL technique for the identification and anomaly detection of each organ, and the collaborative phase to make all the algorithms work together in providing a 'second' opinion.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Second trimester pregnant women

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Craiova

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Smaranda Belciug, Assoc. Prof.

Role: PRINCIPAL_INVESTIGATOR

University of Craiova

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Emergency County Hospital

Craiova, Dolj, Romania

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Romania

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Smaranda Belciug, Assoc. Prof.

Role: CONTACT

729127574 ext. +40

Dominic G Iliescu, Assoc. Prof.

Role: CONTACT

723888773 ext. +40

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dominic G Iliescu, Assoc.Prof.

Role: primary

723888773 ext. +40

References

Explore related publications, articles, or registry entries linked to this study.

Belciug S. Learning deep neural networks' architectures using differential evolution. Case study: Medical imaging processing. Comput Biol Med. 2022 Jul;146:105623. doi: 10.1016/j.compbiomed.2022.105623. Epub 2022 May 17.

Reference Type RESULT
PMID: 35751202 (View on PubMed)

Belciug S, Ivanescu RC, Popa SD, Iliescu DG. Doctor/Data Scientist/Artificial Intelligence Communication Model. Case Study. Procedia Comput Sci. 2022;214:18-25. doi: 10.1016/j.procs.2022.11.143. Epub 2022 Dec 8.

Reference Type RESULT
PMID: 36514710 (View on PubMed)

Belciug S. Autonomous fetal morphology scan: deep learning + clustering merger - the second pair of eyes behind the doctor. BMC Med Inform Decis Mak. 2024 Apr 19;24(1):102. doi: 10.1186/s12911-024-02505-3.

Reference Type DERIVED
PMID: 38641580 (View on PubMed)

Belciug S, Ivanescu RC, Serbanescu MS, Ispas F, Nagy R, Comanescu CM, Istrate-Ofiteru A, Iliescu DG. Pattern Recognition and Anomaly Detection in fetal morphology using Deep Learning and Statistical learning (PARADISE): protocol for the development of an intelligent decision support system using fetal morphology ultrasound scan to detect fetal congenital anomaly detection. BMJ Open. 2024 Feb 15;14(2):e077366. doi: 10.1136/bmjopen-2023-077366.

Reference Type DERIVED
PMID: 38365300 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PARADISE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Outcome of Fetal Spina Bifida
NCT01100697 COMPLETED
Digital Dysmorphology Project
NCT02651493 UNKNOWN NA
Trial Observationnal
NCT05785338 COMPLETED